SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

SNAP is trending after a post-earnings sell-off, with the community actively debating whether strong quarterly results and a share buyback are overshadowed by persistent concerns about high stock-based compensation and dilution, amid long-term optimism for AI/AR innovations.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is trending after its Q4 earnings report, where strong profitability and a strategic shift towards prudent risk management were met with a severe market sell-off due to conservative revenue guidance and prevailing fintech sector weakness. The community is sharply divided, with many calling the stock oversold and deeply undervalued while others express frustration over management's outlook and perceived manipulation.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending as it opens its 30,000th store, including a new premium flagship, coinciding with rival Cotti Coffee reportedly ending its aggressive discount strategy. This development is driving community discussions around potential margin expansion and the company's significant undervaluation compared to competitors.

Kyndryl Holdings, Inc. is a technology services company, which engages in the provision of infrastructure services. It operates through the following segments: United States, Japan, Principal Markets, and Strategic Markets. The Principal Markets segment represents the aggregation of operations in Australia, New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, the United Kingdom, and Ireland. The company was founded on December 4, 2020 and is headquartered in New York, NY.

Kyndryl Holdings Inc

Kyndryl Holdings is plummeting after the abrupt departures of its CFO and general counsel amid an SEC accounting investigation, sparking intense community discussion on whether the severe market reaction presents a bargain opportunity or signals deeper issues akin to prior corporate collapses.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is seeing intense discussion around its pivotal role in the AI-nuclear nexus, fueled by its power development partnership with Meta and anticipated DOE plutonium awards, though persistent insider selling and its pre-revenue status are generating fierce debate and price swings.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

Recent exchange listings and extensive utility enhancements for BankrCoin's AI-powered trading agents on the Base ecosystem are driving intense community discussion, with many anticipating significant price discovery despite lingering "pump and dump" concerns.

Amentum Holdings, Inc. engages in mission-critical, technology-driven services in government and commercial markets. It operates through the Digital Solutions and Global Engineering Solutions segments. The Digital Solutions segment provides advanced digital and data-driven solutions including intelligence analytics, space system development, cybersecurity, and next generation IT. The Global Engineering Solutions segment manages large-scale environmental remediation, nuclear power solutions, platform engineering, sustainment and supply chain management. The company was founded on November 26, 2019 and is headquartered in Chantilly, VA.

Amentum Holdings Inc.

Amentum Holdings is actively discussed after its latest earnings report, which saw an EPS beat but a revenue miss largely due to contract transitions and a government shutdown, leading to divided community sentiment with many investors calling the stock's decline an overreaction and a long-term buying opportunity given its substantial backlog in nuclear, space, and defense programs.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio is trending following the FDA's Complete Response Letter for its RGX-121 gene therapy for Hunter syndrome, citing issues with trial design and the use of natural history controls. The community is now intensely discussing the severe financial impact on the company and potential ramifications for its other gene therapy programs and the broader sector.

Haverty Furniture Cos., Inc. engages in the retail of residential furniture and accessories. Its products are Tempur-Pedic, Serta, Stearns and Foster, Beautyrest, and Sealy. The company was founded by James Joseph Haverty in 1885 and is headquartered in Atlanta, GA.

Haverty Furniture Cos., Inc. - Ordinary Shares - Class A

Haverty Furniture (HVT.A) is trending following a notable price jump, sparking significant community excitement and discussion about potential profit opportunities.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

ROOT is trending amidst upcoming Q4 earnings and recent partnership announcements, including a new integration with Kikoff and strong speculation around a Hyundai white-label deal, which bulls believe will drive significant growth. However, persistent stock declines, perceived market manipulation by shorts and insiders, and community frustration with CEO Alex Timm's communication have created a highly polarized sentiment, despite the company's reported operational improvements and profitability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FY2025 Earnings Forecast for CGTX Issued By Brookline Cap M

Cognition Therapeutics, Inc. (NASDAQ:CGTX - Free Report) - Investment analysts at Brookline Cap M issued their FY2025 EPS estimates for Cognition Therapeutics in a research note issued to investors...

Cognition Therapeutics (NASDAQ:CGTX) Upgraded to Strong-Buy at Brookline Cap M

Brookline Cap M raised shares of Cognition Therapeutics to a "strong-buy" rating in a research report on Tuesday...

Brookline Capital Management Predicts CGTX FY2025 Earnings

Cognition Therapeutics, Inc. (NASDAQ:CGTX - Free Report) - Brookline Capital Management issued their FY2025 earnings estimates for shares of Cognition Therapeutics in a research report issued on...

Cognition Therapeutics, Inc. (NASDAQ:CGTX) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of Cognition Therapeutics, Inc. (NASDAQ:CGTX - Get Free Report) have earned an average rating of "Moderate Buy" from the five ratings firms that are currently covering the firm, MarketBeat...

Cognition Therapeutics (NASDAQ:CGTX) Raised to "Strong-Buy" at Brookline Capital Management

Brookline Capital Management raised shares of Cognition Therapeutics to a "strong-buy" rating in a research report on Tuesday...

DAVENPORT & Co LLC Makes New Investment in Cognition Therapeutics, Inc. $CGTX

DAVENPORT & Co LLC purchased a new stake in Cognition Therapeutics, Inc. (NASDAQ:CGTX - Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The fund purchased 2,689,336...

Cognition Therapeutics, Inc. (NASDAQ:CGTX) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Cognition Therapeutics, Inc. (NASDAQ:CGTX - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the five brokerages that are currently covering the firm...

Cognition Therapeutics (NASDAQ:CGTX) Earns "Buy" Rating from HC Wainwright

HC Wainwright reiterated a "buy" rating and issued a $3.00 price objective on shares of Cognition Therapeutics in a research report on Thursday...

Q1 Earnings Forecast for CGTX Issued By B. Riley

Cognition Therapeutics, Inc. (NASDAQ:CGTX - Free Report) - Equities research analysts at B. Riley issued their Q1 2026 earnings per share estimates for Cognition Therapeutics in a report issued on...

Cognition Therapeutics, Inc. (NASDAQ:CGTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of Cognition Therapeutics, Inc. (NASDAQ:CGTX - Get Free Report) have been given a consensus rating of "Moderate Buy" by the five brokerages that are covering the stock, MarketBeat.com reports...

Cognition Therapeutics, Inc. is a clinical stage neuroscience company which engages in developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders. It offers the CT1812 which aims to restore the damaged cellular processes that drive diseases such as Alzheimer’s disease, dry age-related macular degeneration, geographic atrophy and other conditions. The company was founded by Franz F. Hefti, Gilbert M. Rishton, and Susan M. Catalano on August 21, 2007 and is headquartered in Purchase, NY.

Cognition Therapeutics Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $HOOD earnings on Tuesday?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.08	--	--	N/A
Q3 '25	-$0.09	-$0.06	33.33%	BEAT
Q2 '25	-$0.10	-$0.11	-4.76%	MISSED
Q1 '25	-$0.12	-$0.14	-20.69%	MISSED
Q4 '24	-$0.17	-$0.19	-10.99%	MISSED

CGTX
Cognition Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '25

Historical Earnings

Latest CGTX News

CGTXCognition Therapeutics Inc